 | • レポートコード：MRC309Z0206 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（2-3営業日） • 産業分類：化学＆材料 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界のベータニコチンアミドモノヌクレオチド（NMN）の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界のベータニコチンアミドモノヌクレオチド（NMN）市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - ベータニコチンアミドモノヌクレオチド（NMN）の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため ベータニコチンアミドモノヌクレオチド（NMN）市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・含有率98%以上、含有率98%以下 用途別セグメント ・医療用製品、化粧品、その他 主要な市場プレーヤー ・GeneHarbor、Herbalmax、Genex Formulas、Shinkowa Pharmaceutical、Maac10 Formulas、EffePharm、Bontac、CELFULL、Kingdomway 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ベータニコチンアミドモノヌクレオチド（NMN）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なベータニコチンアミドモノヌクレオチド（NMN）メーカーの企業概要、2019年～2022年までのベータニコチンアミドモノヌクレオチド（NMN）の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なベータニコチンアミドモノヌクレオチド（NMN）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別ベータニコチンアミドモノヌクレオチド（NMN）の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までのベータニコチンアミドモノヌクレオチド（NMN）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのベータニコチンアミドモノヌクレオチド（NMN）市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、およびベータニコチンアミドモノヌクレオチド（NMN）の産業チェーンを掲載しています。 ・第14、15章では、ベータニコチンアミドモノヌクレオチド（NMN）の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - ベータニコチンアミドモノヌクレオチド（NMN）の概要 - 種類別分析（2018年vs2022年vs2029年）：含有率98%以上、含有率98%以下 - 用途別分析（2018年vs2022年vs2029年）：医療用製品、化粧品、その他 - 世界のベータニコチンアミドモノヌクレオチド（NMN）市場規模・予測 - 世界のベータニコチンアミドモノヌクレオチド（NMN）生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - GeneHarbor、Herbalmax、Genex Formulas、Shinkowa Pharmaceutical、Maac10 Formulas、EffePharm、Bontac、CELFULL、Kingdomway ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：含有率98%以上、含有率98%以下 ・用途別分析2018年-2029年：医療用製品、化粧品、その他 ・ベータニコチンアミドモノヌクレオチド（NMN）の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・ベータニコチンアミドモノヌクレオチド（NMN）のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・ベータニコチンアミドモノヌクレオチド（NMN）のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・ベータニコチンアミドモノヌクレオチド（NMN）の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・ベータニコチンアミドモノヌクレオチド（NMN）の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Beta-Nicotinamide Mononucleotide (NMN) market size was valued at USD 306.1 million in 2022 and is forecast to a readjusted size of USD 679.1 million by 2029 with a CAGR of 12.1% during review period.
Beta-Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
Global key players of beta-nicotinamide mononucleotide (NMN) include GeneHarbor, Mirailab Bioscience, EffePharm, Herbalmax and Genex Formulas. Asia-Pacific is the largest producer, holds a share over 60%, followed by North America and Europe. In terms of product type, content greater than or equal to 98% is the largest segment, with a share over 99%. And in terms of application, the largest segment is Health Care Products, with a share over 99%.
The Global Info Research report includes an overview of the development of the Beta-Nicotinamide Mononucleotide (NMN) industry chain, the market status of Health Care Products (Content Greater than or Equal to 98%, Content Less than 98%), Cosmetics (Content Greater than or Equal to 98%, Content Less than 98%), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Beta-Nicotinamide Mononucleotide (NMN).
Regionally, the report analyzes the Beta-Nicotinamide Mononucleotide (NMN) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Beta-Nicotinamide Mononucleotide (NMN) market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Beta-Nicotinamide Mononucleotide (NMN) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Beta-Nicotinamide Mononucleotide (NMN) industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Kg), revenue generated, and market share of different by Type (e.g., Content Greater than or Equal to 98%, Content Less than 98%).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Beta-Nicotinamide Mononucleotide (NMN) market.
Regional Analysis: The report involves examining the Beta-Nicotinamide Mononucleotide (NMN) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Beta-Nicotinamide Mononucleotide (NMN) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Beta-Nicotinamide Mononucleotide (NMN):
Company Analysis: Report covers individual Beta-Nicotinamide Mononucleotide (NMN) manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Beta-Nicotinamide Mononucleotide (NMN) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Health Care Products, Cosmetics).
Technology Analysis: Report covers specific technologies relevant to Beta-Nicotinamide Mononucleotide (NMN). It assesses the current state, advancements, and potential future developments in Beta-Nicotinamide Mononucleotide (NMN) areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Beta-Nicotinamide Mononucleotide (NMN) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Beta-Nicotinamide Mononucleotide (NMN) market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Content Greater than or Equal to 98%
Content Less than 98%
Market segment by Application
Health Care Products
Cosmetics
Others
Major players covered
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Beta-Nicotinamide Mononucleotide (NMN) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Beta-Nicotinamide Mononucleotide (NMN), with price, sales, revenue and global market share of Beta-Nicotinamide Mononucleotide (NMN) from 2018 to 2023.
Chapter 3, the Beta-Nicotinamide Mononucleotide (NMN) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Beta-Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Beta-Nicotinamide Mononucleotide (NMN) market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Beta-Nicotinamide Mononucleotide (NMN).
Chapter 14 and 15, to describe Beta-Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Beta-Nicotinamide Mononucleotide (NMN)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Content Greater than or Equal to 98%
1.3.3 Content Less than 98%
1.4 Market Analysis by Application
1.4.1 Overview: Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Health Care Products
1.4.3 Cosmetics
1.4.4 Others
1.5 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size & Forecast
1.5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity (2018-2029)
1.5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 GeneHarbor
2.1.1 GeneHarbor Details
2.1.2 GeneHarbor Major Business
2.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.1.4 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GeneHarbor Recent Developments/Updates
2.2 Herbalmax
2.2.1 Herbalmax Details
2.2.2 Herbalmax Major Business
2.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.2.4 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Herbalmax Recent Developments/Updates
2.3 Genex Formulas
2.3.1 Genex Formulas Details
2.3.2 Genex Formulas Major Business
2.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.3.4 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Genex Formulas Recent Developments/Updates
2.4 Shinkowa Pharmaceutical
2.4.1 Shinkowa Pharmaceutical Details
2.4.2 Shinkowa Pharmaceutical Major Business
2.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.4.4 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shinkowa Pharmaceutical Recent Developments/Updates
2.5 Maac10 Formulas
2.5.1 Maac10 Formulas Details
2.5.2 Maac10 Formulas Major Business
2.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.5.4 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Maac10 Formulas Recent Developments/Updates
2.6 EffePharm
2.6.1 EffePharm Details
2.6.2 EffePharm Major Business
2.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.6.4 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 EffePharm Recent Developments/Updates
2.7 Bontac
2.7.1 Bontac Details
2.7.2 Bontac Major Business
2.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.7.4 Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bontac Recent Developments/Updates
2.8 CELFULL
2.8.1 CELFULL Details
2.8.2 CELFULL Major Business
2.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.8.4 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 CELFULL Recent Developments/Updates
2.9 Kingdomway
2.9.1 Kingdomway Details
2.9.2 Kingdomway Major Business
2.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product and Services
2.9.4 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Kingdomway Recent Developments/Updates
3 Competitive Environment: Beta-Nicotinamide Mononucleotide (NMN) by Manufacturer
3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Manufacturer (2018-2023)
3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Beta-Nicotinamide Mononucleotide (NMN) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Beta-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2022
3.4.2 Top 6 Beta-Nicotinamide Mononucleotide (NMN) Manufacturer Market Share in 2022
3.5 Beta-Nicotinamide Mononucleotide (NMN) Market: Overall Company Footprint Analysis
3.5.1 Beta-Nicotinamide Mononucleotide (NMN) Market: Region Footprint
3.5.2 Beta-Nicotinamide Mononucleotide (NMN) Market: Company Product Type Footprint
3.5.3 Beta-Nicotinamide Mononucleotide (NMN) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region
4.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2029)
4.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2029)
4.1.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Region (2018-2029)
4.2 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
4.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
4.4 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
4.5 South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
4.6 Middle East and Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Type (2018-2029)
5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
6.2 Global Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Application (2018-2029)
6.3 Global Beta-Nicotinamide Mononucleotide (NMN) Average Price by Application (2018-2029)
7 North America
7.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
7.2 North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
7.3 North America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
7.3.1 North America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
7.3.2 North America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
8.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
8.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
8.3.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
8.3.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Market Size by Region
9.3.1 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
10.2 South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
10.3 South America Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
10.3.1 South America Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
10.3.2 South America Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country
11.3.1 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Beta-Nicotinamide Mononucleotide (NMN) Market Drivers
12.2 Beta-Nicotinamide Mononucleotide (NMN) Market Restraints
12.3 Beta-Nicotinamide Mononucleotide (NMN) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Beta-Nicotinamide Mononucleotide (NMN) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Beta-Nicotinamide Mononucleotide (NMN)
13.3 Beta-Nicotinamide Mononucleotide (NMN) Production Process
13.4 Beta-Nicotinamide Mononucleotide (NMN) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Beta-Nicotinamide Mononucleotide (NMN) Typical Distributors
14.3 Beta-Nicotinamide Mononucleotide (NMN) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
